Literature DB >> 30219649

Clinical impact of dipping and nocturnal blood pressure patterns in newly diagnosed, never-treated patients with essential hypertension.

Eugenia Gkaliagkousi1, Panagiota Anyfanti2, Antonios Lazaridis2, Areti Triantafyllou2, Anastasios Vamvakis2, Nikolaos Koletsos2, Panagiotis Dolgyras2, Stella Douma2.   

Abstract

The significance of nondipping and increased nighttime systolic blood pressure (SBP) in established hypertension is well defined. We investigated whether these factors alone or combined correlate with vascular damage in early-stage hypertension. Newly diagnosed, untreated hypertensives were classified as dippers and nondippers according to ambulatory blood pressure (BP). Twenty-four-hour urinary albumin excretion and markers of arterial stiffness (pulse wave velocity, augmentation index, central and peripheral pulse pressure, central BP) and atherosclerosis (carotid intima-media thickness) were assessed. Serum asymmetric dimethylarginine, an index of endothelial dysfunction, was measured in a study subgroup; 10-year cardiovascular risk was calculated. Among 222 hypertensives, only urinary albumin excretion was increased in nondippers, compared to dippers (P = .026). When dippers were further stratified according to nighttime SBP (<120 or ≥120 mm Hg), the first group demonstrated the lowest levels of office, aortic, 24-hour, daytime and nighttime BP, compared to dippers with elevated nighttime SBP and nondippers. Although vascular measurements and asymmetric dimethylarginine were comparable between these groups, dippers with normal nighttime SBP exhibited the lowest cardiovascular risk score (P = .050). In early-stage hypertension, nondipping was accompanied by microvascular, yet not macrovascular and endothelial dysfunction. Dippers with elevated nighttime SBP appear as a distinct group with increased hemodynamic pressure load and cardiovascular risk.
Copyright © 2018 American Heart Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiovascular risk; dipping/nondipping; endothelial dysfunction; vascular impairment

Year:  2018        PMID: 30219649     DOI: 10.1016/j.jash.2018.08.004

Source DB:  PubMed          Journal:  J Am Soc Hypertens        ISSN: 1878-7436


  6 in total

1.  Nighttime dipping status and risk of cardiovascular events in patients with untreated hypertension: A systematic review and meta-analysis.

Authors:  Maria Gavriilaki; Panagiota Anyfanti; Barbara Nikolaidou; Antonios Lazaridis; Eleni Gavriilaki; Stella Douma; Eugenia Gkaliagkousi
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-11-08       Impact factor: 3.738

2.  Prognostic value of daytime and nighttime blood pressure in treated hypertensives: One size does not fit all.

Authors:  Panagiota Anyfanti; Stella Douma; Eugenia Gkaliagkousi
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-09-10       Impact factor: 3.738

3.  The Tri-ponderal Mass Index is associated with adiposity in adolescent type 2 diabetes mellitus: a cross-sectional analysis.

Authors:  Haifa Alfaraidi; Brandy Wicklow; Allison B Dart; Elizabeth Sellers; Jonathan McGavock; Lehana Thabane; M Constantine Samaan
Journal:  Sci Rep       Date:  2021-04-27       Impact factor: 4.379

4.  Association of Nighttime Systolic Blood Pressure With Left Atrial-Left Ventricular-Arterial Coupling in Hypertension.

Authors:  Qiaobing Sun; Yu Pan; Yixiao Zhao; Yan Liu; Yinong Jiang
Journal:  Front Cardiovasc Med       Date:  2022-02-24

5.  Influence of circadian blood pressure patterns and cardiopulmonary functional capacity in hypertensive patients.

Authors:  Marijana Tadic; Cesare Cuspidi; Jelena Suzic-Lazic; Anita Andric; Carla Sala; Ciro Santoro; Olinka Iracek; Vera Celic
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-08-26       Impact factor: 3.738

6.  Nocturnal dipping status and the association of morning blood pressure surge with subclinical target organ damage in untreated hypertensives.

Authors:  Shenzhen Gong; Kai Liu; Runyu Ye; Jiangbo Li; Changqiang Yang; Xiaoping Chen
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-08-03       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.